Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 boras2021preclinical
%A Boras, B.
%A Jones, R. M.
%A Anson, B. J.
%D 2021
%J Nature Communications
%K covid-19 pfizermectin
%P 6055
%R 10.1038/s41467-021-26239-2
%T Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.
%U https://doi.org/10.1038/s41467-021-26239-2
%V 12
@article{boras2021preclinical,
added-at = {2021-12-05T13:57:40.000+0100},
author = {Boras, B. and Jones, R. M. and Anson, B. J.},
biburl = {https://www.bibsonomy.org/bibtex/24d3ea643beead65faf1e3246dd495b2c/fordham1},
description = {Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 | Nature Communications},
doi = {10.1038/s41467-021-26239-2},
interhash = {e7354d3e4383e2c0a017bc2df6eb8489},
intrahash = {4d3ea643beead65faf1e3246dd495b2c},
journal = {Nature Communications},
keywords = {covid-19 pfizermectin},
pages = 6055,
timestamp = {2021-12-05T18:14:41.000+0100},
title = {Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19. },
url = {https://doi.org/10.1038/s41467-021-26239-2},
volume = 12,
year = 2021
}